The landscape of weight management is rapidly changing , with the emergence of dual GIP and GLP-1 receptor agonists. Both The Tirzepatide and This Retatrutide represent key advancements; Tirzepatid already https://margiezgvk948121.activablog.com/42125834/tirzepatid-retatrutide-a-emerging-metabolic-duo